Trial Details

Not recruiting
Basic Information
Clinical ID c3273
Identifier NCT01022749
Trial Title Prospective, Multicentre, Open-label Study Evaluating the Immunogenicity and Safety of Influenza Vaccine in Patients With Inflammatory Bowel Disease (IBD) Receiving or Not Immunosuppressive Therapy
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Disease (IBD)
Interventions Drug: Vaccine;Biological: Vaccine anti-H1N1
Participant Information
Sponsor Assistance Publique - Hitaux de Paris
City -
Country/Region France
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional
Phase PHASE3
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -